New Data Show NEXTSTELLIS® Has Selective Impact On Endocrine Markers Compared With Common Combined Oral Contraceptives
Results presented at the annual meeting of the International Society for the Study of Women s Sexual Health
News provided by
Share this article
Share this article
RALEIGH, N.C., March 6, 2021 /PRNewswire/ Mayne Pharma announced today new data showing treatment with NEXTSTELLIS®,
1 a novel, investigational combined oral contraceptive (COC) containing drospirenone (DRSP) and estetrol (E4), resulted in limited changes in endocrine markers, including lower increases in hormone binding globulins, compared with COCs based on ethinyl-estradiol (EE), the synthetic estrogen used in all but one of the marketed COCs. The data was presented at the annual meeting of the International Society for the Study of Women s Sexual Health (ISSWSH), held virtually in the U.S. from March 5-7.
New Data Show NEXTSTELLIS® Has Selective Impact On Endocrine Markers Compared With Common Combined Oral Contraceptives prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
(Courtesy of gammaCore)
According to the Department of Veterans Affairs, 36% of veterans returning from Iraq or Afghanistan suffer from severe migraine or cluster headaches.
While doctors can prescribe different drugs, one of America s leading pain management physicians has developed another type of treatment.
Dr. Peter Staats is the cofounder and chief medical officer of electroCore the medical device company that makes gammaCore, a patented device that electrically stimulates the vagus nerve to block the pain signals causing debilitating headaches.
The apparatus is called gammaCore Sapphire. The vagus nerve is the cranial radial nerve in the body, Staats told Military.com. I started this company searching for a solution for airway reactivity and anaphylaxis in an animal model. When we started studying humans, patients were saying, My headaches went away.
When Could The U S Reach COVID-19 Herd Immunity? aarp.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aarp.org Daily Mail and Mail on Sunday newspapers.
In part, because of COVID-19 restrictions and mask wearing, flu cases and deaths remain remarkably low compared to last season. While that’s good news, there may be cause for concern for next year’s flu season.